Cargando…
Cardiovascular Risk Predictors High Sensitivity C-Reactive Protein and Plasminogen Activator Inhibitor-1 in Women with Lean Phenotype of Polycystic Ovarian Syndrome: A Prospective Case-Control Study
Objective Accumulating evidence suggests increased cardiovascular risk in women with polycystic ovarian syndrome (PCOS) due to a cluster of factors, such as obesity, lipid abnormalities, impaired glucose tolerance (IGT), and hypertension. Markers such as high-sensitivity C-reactive protein (hs-CRP)...
Autores principales: | Shah, Ashok K., Yadav, Birendra K., Shah, Amrendra K., Suri, Arpita, Deo, Saurabh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104710/ https://www.ncbi.nlm.nih.gov/pubmed/37064963 http://dx.doi.org/10.1055/s-0042-1750066 |
Ejemplares similares
-
Clinico-Metabolic Profile in Lean Versus Obese Polycystic Ovarian Syndrome Women
por: Makhija, Nidhi, et al.
Publicado: (2023) -
Liraglutide Improves Hypertension and Metabolic Perturbation in a Rat Model of Polycystic Ovarian Syndrome
por: Hoang, Vanessa, et al.
Publicado: (2015) -
Correlation of Cutaneous Manifestations with Body Mass Index, Blood Glucose, and Hormonal Levels in Patients with Polycystic Ovarian Disease
por: Sharma, Yugal K., et al.
Publicado: (2020) -
Comparison of clinical features and health manifestations in lean vs. obese Indian women with polycystic ovarian syndrome
por: Majumdar, Abha, et al.
Publicado: (2009) -
Should Women with Polycystic Ovarian Syndrome be Prioritized to Receive the COVID Vaccine?
por: Shah, Duru
Publicado: (2021)